Literature DB >> 16782836

Neural and hydroxyl radical mechanisms underlying laryngeal airway hyperreactivity induced by laryngeal acid-pepsin insult in anesthetized rats.

Tung-Lung Tsai1, Shyue-Yih Chang, Chin-Yin Ho, Yu Ru Kou.   

Abstract

Laryngopharyngeal or gastroesophageal reflux is associated with laryngeal airway hyperreactivity (LAH), but neither the cause-effect relationship nor the underlying mechanism has been elucidated. Here we established a rat model with enhanced laryngeal reflex reactivity induced by laryngeal acid-pepsin insult and investigated the neural and hydroxyl radical (*OH) mechanisms involved. The laryngeal segments of 103 anesthetized rats were functionally isolated while animals breathed spontaneously. Ammonia vapor was delivered into the laryngeal segment to measure laryngeal reflex reactivity. We found that the laryngeal pH 5-pepsin treatment doubled the reflex apneic response to ammonia, whereas laryngeal pH 7.4-pepsin, pH 2-pepsin, and pH 5-denatured pepsin treatment had no effect. Histological examination revealed limited laryngeal inflammation and epithelial damage after pH 5-pepsin treatment and more severe damage after pH 2-pepsin treatment. In rats that had received the laryngeal pH 5-pepsin treatment, the apneic response to ammonia was abolished by either denervation or perineural capsaicin treatment (PCT; a procedure that selectively blocks capsaicin-sensitive afferent fibers) of the superior laryngeal nerves, but was unaffected by perineural sham treatment. LAH was prevented by laryngeal application of either dimethylthiourea (DMTU; a *OH scavenger) or deferoxamine (DEF; an antioxidant for *OH), but was unaltered by the DMTU vehicle or iron-saturated DEF (ineffective DEF). LAH reappeared after recovery from PCT, DMTU, or DEF treatment. We conclude that 1) laryngeal insult by pepsin at a weakly acidic pH, but not at acidic pH, can produce LAH; and 2) LAH is probably mediated through sensitization of the capsaicin-sensitive laryngeal afferent fibers by a *OH mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782836     DOI: 10.1152/japplphysiol.00064.2006

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

Review 1.  Laryngeal Chemoreflex in Health and Disease: A Review.

Authors:  Shivani Pathak; Laurie Slovarp; Matthew S Clary; Marie E Jetté
Journal:  Chem Senses       Date:  2020-12-05       Impact factor: 3.160

2.  Acute stress to excised vocal fold epithelium from reactive oxygen species.

Authors:  Rebecca Alper; Xue Fu; Elizabeth Erickson-Levendoski; Wei Zheng; Mahalakshmi Sivasankar
Journal:  Laryngoscope       Date:  2011-09-06       Impact factor: 3.325

3.  Combined laryngeal inflammation and trauma mediate long-lasting immunoreactivity response in the brainstem sensory nuclei in the rat.

Authors:  Kristina Simonyan; Xin Feng; Victor M Henriquez; Christy L Ludlow
Journal:  Front Integr Neurosci       Date:  2012-11-15

4.  Lesions in the Larynx of Wistar RccHan: WIST Rats.

Authors:  Klaus Weber; Paul-Georg Germann; Hijiri Iwata; Jerry Hardisty; Wolfgang Kaufmann; Martin Rosenbruch
Journal:  J Toxicol Pathol       Date:  2009-12-21       Impact factor: 1.628

5.  NADPH Oxidase-Derived ROS Induced by Chronic Intermittent Hypoxia Mediates Hypersensitivity of Lung Vagal C Fibers in Rats.

Authors:  Chang-Huan Yang; Wei-Ling Zhuang; Yan-Jhih Shen; Ching Jung Lai; Yu Ru Kou
Journal:  Front Physiol       Date:  2016-05-09       Impact factor: 4.566

6.  Sensitization by pulmonary reactive oxygen species of rat vagal lung C-fibers: the roles of the TRPV1, TRPA1, and P2X receptors.

Authors:  Ting Ruan; Yu-Jung Lin; Tien-Huan Hsu; Shing-Hwa Lu; Guey-Mei Jow; Yu Ru Kou
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

7.  Inflammatory Role of ROS-Sensitive AMP-Activated Protein Kinase in the Hypersensitivity of Lung Vagal C Fibers Induced by Intermittent Hypoxia in Rats.

Authors:  Chang-Huan Yang; Yan-Jhih Shen; Ching Jung Lai; Yu Ru Kou
Journal:  Front Physiol       Date:  2016-06-27       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.